The rise of antibody therapeutics is transforming drug discovery, providing highly specific treatments for complex diseases ...

A small clinical trial shows promising results for patients with triple-negative breast cancer who received an ...

Immune-cell therapy shrank children's brain tumors, restored neurologic function and—for one participant—erased all detectable traces of a brain cancer.

AiBST, founded in 2002, is developing research competence in drug discovery on the continent. To help address efficacy differences, AiBST has developed an inclusive genetic test which considers varied ...